isg chennai march 2015 rajasekar
TRANSCRIPT
Cadaveric Liver Transplantation - Where do ‘we’ stand Today
Dr. Rajasekhar PerumallaMS, FRCS
Senior Consultant Transplant SurgeonSIMS (SRM Institute of Medical Sciences)
VadapalaniChennai
Important milestones in transplantation
Dr.Thomas Starzl
1963- Denver, Colarado,US• INTRODUCTION OF CYCLOSPORINE
A – JEAN BOREL• SIR ROY CALNE – CAMBRIDGE
UNIVERSITYInitial results 130 LTX by 1970, 12 alive in 1976Scope for improvement
Transplant scenario in India
Brain Death and deceased donor organ donation is legal - Human Organ transplantation Act 1994
Liver transplant - First DDLT - 1998First LDLT - 1999 (Paediatric)First LDLT - 2000 (Adult)
Transplants Oct 2008 to Jan 2015
Donors From TN 587 Heart 116 Lung 50 Liver 542 Kidney 1052 Pancreas 4 Small Bowel 1 Total Major organs 1765 Heart Valve566 Cornea 886 Skin 13
Total Organs 3231
Liver transplant - survival
1 year survival - 88- 90% 2 year survival - 80- 85% 5 Year survival - 70- 75%
Complication rate – 10- 15%Artery, Bile duct, Infection, rejection
Improved outcomes
Patient selection Organ preservation Refined surgery & anaesthesia Immunosuppression Early recognition of complications &
management
Prognostic Models
CTP Score MELD score
Importance of HCC screening in Cirrhotics
6 monthly AFP and Ultrasound
Deceased Donor Vs Living Donor – Which to offer and when?
Time available for the Recipient -Stable – Can waitStable – not ideal to waitUnstable
Donor
Deceased donor 1. Brain Dead Donor2. DCD (Donation after cardiac
death) Organ preservation time
Liver – 12 -24 hrs Whole organ / Reduced graft / Split
Organ harvesting /Procurement
Laparotomy/Asessment Aortic cannulation Portal cannulation Goal: Cool the organs and perfuse
with preservative solution (HTK (Custodial)
UW (Belzer) while exsanguinating the organs
Cold Ischemia Time
Retrieval of liver following clamping the Aorta
Packaging and Transport Recipient Hepatectomy Implantation of New Liver –
Vena Caval anastomosis, Portal Vein Anastomosis, Reperfusion
TOTAL TIME 6 – 12 hrs.Always a race against Time!
Selection Selection of transplant type depends on Organ availability ABO match Physical size (HT, WT, Abdominal girth) Medical condition - MELD, CTP score) Age match – Donor / Recipient DDLT preferred in a recipient
High BMI Portal vein thrombosis Re-transplantation Sick recipients
In India: organ shortage
DDLT- Is there a need for Speed?
Keys to a safe and quick transplant Prepare well - Know your patient, review the
case history, diagnosis & Lab values. Review the CT scan & Know the anatomy Start slowly, progress gradually with careful
mobilisation of liver & no traction Ensure haemostasis at every step
DDLT is usually faster Implantation is less complex & quicker
DDLT Emergency - Race against time to CIT
Recipient hepatectomy
Level of dissection
High ligation of the hilar structures: Arteries and bile ducts
Beware of vascular intimal dissection
LDLT- High ligation of structures
Cava preserving hepatectomy
Preferred technique
Avoids caval clamping
Could be avoided in select DDLT cases.
Veno venous bypass
Difficult hepatectomy
Caudate lobe hypertrophySevere portal hypertensionVolume overload- Tissue oedemaRetransplantationPrevious upper abdominal surgeryAbdominal cocoon
Temporary porto caval shunt Belghiti et al
Difficult recipient hepatectomyTraining periodNo portal hypertension
Acute liver failure Non cirrhotic
Implantation - Classic technique
Hepatic vein implantation
DDLT
Piggyback technique Preferred Single cava
anastamosis Cavacavoplasty
Side to side cavo-caval Caval replacement
Budd chiari syndrome Massive caudate lobe Retransplantation
LDLT
Multiple veins to be drained
RHV in right lobe grafts
Seg 5/8/ IRHV reconstruction
Caval anastomosis – “pyggy-back” technique
Caval anastomosis – Belghiti technique
Final aspect of anastomoses
1. Hepatectomy – can sometimes be the toughest2. Anhepatic Phase – Major role for Anesthesiologist3. Reperfusion – “ Anesthesia- watch for Toxin release
to the heart , Surgeons - Watch for golden bile”
Good graft function
Haemodynamic stability Awakening from anesthesia Clearence of lactate Resolution of hypoglycemia Normalisation of coagulation profile Resolution of elevated transaminases Bile (Golden) production on the table
Uncomplicated post op period
Stable Haemodynamics- Minimum to no inotropes
Patient wakes up - 1- 2 hrs. Acid base balance Extubation – 4-6 hrs. Doppler – day 1 Out of ICU to wards Diet – NE feeds 6 hrs. to 12 hrs. OUT OF HOSPITAL – 10 -14 days
Factors? : Immediate outcome
Graft selection / Graft quality Organ preservation Warm & cold ischaemia times Donor – Recipient matching Surgical & Medical problems
Post Op Care –MULTI-FACETED APPROACH
FLUID AND ELECTROLYTE BALANCE
RESPIRATORY STATUS RENAL FUNCTION – RRT INFECTION CONTROL IMMUNO-SUPPRESSION IMAGING ALL THE
‘PLUMBING’
Early complications
Primary Non Function of Graft (2%) Delayed Graft Function Technical (Arterial, bile duct) 10-
12% Acute Rejection Infection
Post Transplant Phase - PNF
Age Electrolyte imbalance Inotropes Prolonged ICU stay CIT PNF Prevention
Careful management of donor
Long Term Complications
Recurrence of primary disease Metabolic complications –
Hypertension Renal failure Dyslipidemia PTDM (Immunosuppression related)
Malignancy- PTLD, Skin tumors
Care of Transplant Patient
Primary Care physician
Hepatologist
Transplant Team
Expansion of the Organ Donor Pool
Improving results Increasing demand Scanty resource Decrease the waiting list
mortality Efforts are on to expand the pool
Future?
ORGAN SUPPLY – “Political”
Opting out system (Spanish model)
Infrastructure? ITU beds
ORGAN SUPPLY – Surgical
Using marginal grafts
Resuscitation of grafts Ischaemic preconditioning
Avoidance of cold ischaemia
Fewer technical complications
Split liver for 2 adults
Future?
The First Split & Auxiliary Liver Transplant in India was performed by Prof Mohamed Rela and his team to save the lives of two different individuals.
Ms. Himani Koshala and Ms. Kamala Bulledulla
1919thth September 2009 September 2009
Split the liver graft for 2 adult recipients
Ex-situ Split Liver TransplantationKing’s College Hospital – Survival data
n 1 yr 3 yr 5 yr
Overall patient survival 256 87% 84% 84%
Patient survival – LLS 140 90% 88% 88%
Patient survival – RL 116 85% 81% 80%
Results of Ex-situSplit Liver Transplantation
Author Year Number Age group Technique Patient Graft
Survival % Survival %
Broelsch et al 1990 30 Adults Ex situ 67 55
Otte et al 1995 29 Mixed Ex situ 79 69De Ville et al 1995 96 Mixed Ex situ 71 64
Azoulay et al 1995 27 Mixed Ex situ 79 79
Rela et al 1998 41 Mixed Ex situ 90 88Mirza et al 1998 24 Mixed Ex situ 78 68
Reyes et al 2000 12 Paediatric Ex situ 64 4513 Adult Ex situ 83 -
Azoulay et al 2001 34 Adult Ex situ 88 (LLS) 74 (RL)
Kings 2001 156 Mixed Ex Situ 88.6 88
Biliary anatomy of Caudate Lobe
Marginal Donor
Definition Organs considered unsuitable for
transplantation are currently being used.
New Terminology “Marginal” donor, “Expanded” donor “Extended criteria” donor
Marginal Donor Older donors Diabetes mellitus Hypertension Renal insufficiency Selected cases
Hepatitis B & C HIV
Marginal Donor-Disadvantages
risk of delayed graft function Primary non function (PNF)
Assessment Extended Criteria Donor
Donor age and history Donor haemodynamics Donor Anatomy Donor liver Biopsy Pump parameters Recipient selection
important
Steatotic graft Western population: steatosis is prevalent in
30 to 70% of people Most common type of ‘‘extended criteria’’
organs Problems – depending on severity of steatosis
Primary/delayed function Post transplant complications Poor long-term outcomes ??
Nocito A, et al. J Hepatol 2006;45:494–499
Steatotic Graft - Assessment
Assessment Visual inspection and palpation Biopsy – Two cores from the right and left liver were
regarded to best predict overall liver histological characteristics
Frozen section may overestimate
Hepatic Steatosis Quantitative evaluation - based on the
percentage of hepatocytes containing cytoplasmic fat inclusions Mild - ≥ 30% Moderate - 30 -60%, Severe - > 60%
Fatty infiltration - Two categories Macrosteatosis Microsteatosis
1.
Donor Risk Index
May be acceptable to transplant with up to 60% steatosis in the graft
McCormack L, et al. Journal of Hepatology 2011; 54: 1055–1062
Cold ischemic time 5hrs. for grafts with steatosis
Consider donor < 40 year Recipient MELD:
Those with low MELD seem to tolerate steatotic grafts betterBest scenario would be use this for low MELD score recipients with urgency such as those with HCC
Long term outcome
Steatotic Graft show a dramatic decrease in fatty infiltration after LT
Mechanism – not fully understood Factors that negatively affect this reversal of steatosis - donor age
(>50 years) and prolonged cold ischemia time (>12 h) Severe macrosteatosis : Biliary complications Steatosis in the liver graft – negative prognostic factor
for HCV recurrence Literature is divided on the effect of donor graft steatosis as a
facilitator or stimulator of fibrosis on patients with post-LT HCV recurrence
Baccarani U, et al. Clin Transplant 2009.
Li J, et al. Transplant Proc 2009;41: 3560–3563.
Future Challenges Ongoing work by the Pioneers
Long Term Complications IMMUNE Tolerance
Ever Increasing Demand Xenotransplantation
LIVER TX– TEAM EFFORT
TX SURGEONS ANESTHESIOLOGISTHEPATOLOGISTINTENSIVISTSCRUB NURSEPERFUSIONISTDIALYSIS TECHNICIANSBLOOD BANKPATHOLOGISTLAB PERSONNELTX COORDINATORS
Don’t take your Organs to heaven, heaven knows we need
them here.
Thank you